Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-Inhibitor Drug Trial in Coronary Angioplasty
NCT00000510Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Sep 1983
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of dipyridamole, aspirin in coronary artery disease (CAD), sponsored by National Heart, Lung, and Blood Institute. Started Sep 1983; status: completed.
02
Drugs
dipyridamoleaspirin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00000510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000510.